IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 29 filers reported holding IMMUCELL CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,654 | +17.8% | 53,213 | +16.4% | 0.00% | – |
| Q2 2023 | $233,207 | +18.9% | 45,727 | +20.1% | 0.00% | – |
| Q1 2023 | $196,122 | +84072.5% | 38,082 | 0.0% | 0.00% | – |
| Q4 2022 | $233 | -99.9% | 38,082 | -0.1% | 0.00% | – |
| Q3 2022 | $285,000 | +39.7% | 38,135 | +61.8% | 0.00% | – |
| Q2 2022 | $204,000 | -6.4% | 23,573 | +4.0% | 0.00% | – |
| Q1 2022 | $218,000 | +21.8% | 22,672 | +1.0% | 0.00% | – |
| Q4 2021 | $179,000 | -13.5% | 22,442 | 0.0% | 0.00% | – |
| Q3 2021 | $207,000 | +6.7% | 22,442 | +9.8% | 0.00% | – |
| Q2 2021 | $194,000 | -1.0% | 20,434 | 0.0% | 0.00% | – |
| Q1 2021 | $196,000 | +62.0% | 20,434 | 0.0% | 0.00% | – |
| Q4 2020 | $121,000 | +10.0% | 20,434 | 0.0% | 0.00% | – |
| Q3 2020 | $110,000 | +14.6% | 20,434 | 0.0% | 0.00% | – |
| Q2 2020 | $96,000 | +24.7% | 20,434 | 0.0% | 0.00% | – |
| Q1 2020 | $77,000 | – | 20,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Financial Services, Inc. | 23,776 | $89,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 51,263 | $192,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 254 | $1,000 | 0.00% |
| Creative Planning | 310 | $1,000 | 0.00% |
| Renaissance Technologies | 10,000 | $38,000 | 0.00% |
| UBS AG | 1,870 | $7,000 | 0.00% |
| US BANCORP \DE\ | 24 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,032 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
| MORGAN STANLEY | 29,628 | $111,000 | 0.00% |